AI-Designed Minibinders Target ERO1A–PDIA1 Redox Axis in Triple-Negative Breast Cancer
Triple-negative breast cancer has long presented one of oncology’s most difficult challenges: it lacks the three molecular markers—estrogen receptor, progesterone ...
